Nov 17, 2014 5:48pm EST Can-Fite Announces Special General Meeting of Shareholders to Elect External Director
Nov 13, 2014 7:00am EST Can-Fite CEO Dr. Pnina Fishman to Present Recently Released Positive Data from its Rheumatoid Arthritis Phase IIb Study at the 2014 American College of Rheumatology Annual Meeting
Oct 07, 2014 7:00am EDT Can-Fite CEO Dr. Pnina Fishman to Co-Chair and Present at the 19th World Congress on Advances in Oncology's Cancer Therapeutics Session
Sep 30, 2014 7:00am EDT U.S. Patent and Trademark Office Issues Can-Fite Patent for CF102 in the Treatment of Liver Regeneration and Function Following Surgery
Sep 17, 2014 7:00am EDT Can Fite's Drug CF101 is Presented in Scientific Journal as One of Four Small Molecule Drugs for the Treatment of Psoriasis
Sep 05, 2014 7:00am EDT Can-Fite Issued Japanese Patent for CF102 in the Treatment of Liver Regeneration and Function Following Surgery
Sep 03, 2014 7:00am EDT Can-Fite to Present at Rodman & Renshaw Global Investment Conference in New York City on September 9, 2014
